The NAD+ biosynthetic pathway drives immunosuppression in high-grade serous ovarian cancer — ScienceD... - Verve Times


3/16/2022 12:00:00 AM3 years 1 month ago
by Addrew Shawn

High-grade serous carcinoma is the most aggressive form of ovarian cancer and accounts for the majority of advanced-stage cases. The poor outcomes associated with the disease underscore the need for more effective treatments. A research team led by K

High-grade serous carcinoma is the most aggressive form of ovarian cancer and accounts for the majority of advanced-stage cases. The poor outcomes associated with the disease underscore the need for … [+4783 chars]

full article...